Fig 1: Liver analysis following 12 wks of allulose consumption. Liver mass was measured (A) prior to the analysis of glycogen (B) and triglycerides (C) following 12 wks of a Western diet (WD) and standard diet (SD) with stevia or allulose in the drinking water. Mitochondrial respiration (see Section 2) was measured to determine any direct impact of diet on function (D). The liver enzymes alanine (ALT) and aspartate aminotransferase (AST) were quantified (E) in the plasma as a marker of liver health. N = 8. * p < 0.05; ** p < 0.005; *** p < 0.0005 vs. SD+stevia.
Fig 2: Worm burden, antibodies, and liver damage assessment. Samples were harvested following two different treatment time points. Adult C. sinensis worms were recovered from the bile ducts of rats and quantified to calculate worm recovery (A). ELISA was performed using the sera (B) and duodenal samples (C) of rats to determine C. sinensis-specific antibody responses. ALT (D) and AST (E) concentrations in serum samples were evaluated. Statistical significances are indicated using asterisks (* p < 0.05, ** p < 0.01).
Fig 3: Effects of rifaximin and L-carnitine on hepatic phenotypes in CDAA-fed rats. (A) Experimental protocols. (B) Changes in the body weight of the rats during the experimental period. The comparison was performed between the groups at the last time point. (C) Ratio of liver weight to body weight at the end of the experiment. (D-F) Blood levels of ALT, albumin and NH3. (G) Representative microphotographs of liver sections stained with H&E and Sirius Red in the experimental groups. Scale bar, 50 μm. (H) Hepatic concentrations of TG. (I) Relative mRNA expression levels of Srebf1 and Cpt1a in the liver of experimental rats. (J) Semi-quantification of Sirius Red-stained fibrotic area in high-power field using ImageJ software. (K) Relative mRNA expression levels of Acta2 and Col1a1 in the livers of experimental rats. The mRNA expression levels were measured using reverse transcription-quantitative PCR, and Gapdh was used as an internal control. Histochemical quantitative analyses included five fields per section. (I-K) Quantitative values are indicated as fold changes relative to the values of CSAA group. Data are the mean ± SD (n=10), *P<0.05 and **P<0.01, significant difference between groups. N.S, not significant; N.D, not detected; CDAA, choline-deficient L-amino acid-defined diet; CSAA, choline-sufficient amino acid-defined diet; ALT, alanine aminotransferase; NH3, ammonia; H&E, hematoxylin and eosin; TG, triglycerides; RFX, rifaximin; L-CAR, L-carnitine; Srebf1, sterol regulatory element binding transcription factor 1; Cpt1a, carnitine palmitoyltransferase 1A; Acta2, actin alpha 2, smooth muscle; Col1a1, collagen type i alpha 1 chain.
Fig 4: Worm burden, antibodies, and liver damage assessment. Samples were harvested following two different treatment time points. Adult C. sinensis worms were recovered from the bile ducts of rats and quantified to calculate worm recovery (A). ELISA was performed using sera (B) and duodenal samples (C) of rats to determine C. sinensis-specific antibody responses. ALT (D) and AST (E) concentrations in serum samples were evaluated. Statistical significance was indicated using asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001).
Fig 5: Effects of J1/J2 on ALT and AST. ALT (A) and AST (B) were measured using plasma samples. There was no significant difference in ALT level between the CG and JG groups, but the level of AST was lower in the JG groups, compared to the CG group. Data was analyzed using the t-test method and data is presented as the mean ± SD (n = 10) with p-value and d (Cohen’s d) value. The mark (*) indicates statistical significance compared to the CG group (p < 0.05).
Supplier Page from Abcam for Rat Alanine Aminotransferase (ALT) ELISA Kit